Equity-Based Compensation (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
Share-Based Payment Arrangement [Abstract] |
|
Nonvested Stock Units Activity |
| | | | | | | | | | | | Six Months Ended June 30, 2025 | | | | | | Weighted Average Grant Date Fair Value | | | | Weighted Average Grant Date Fair Value | | Unvested at beginning of period | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unvested at end of period | | | | | | | | | |
| | | | | | | | | | | | Six Months Ended June 30, 2025 | | | | | | | | | | | | Weighted Average Grant Date Fair Value | | | | Weighted Average Grant Date Fair Value | | Unvested at beginning of period | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unvested at end of period | | | | | | | | | |
| | | | | | | | | | | | Six Months Ended June 30, 2025 | | | | | | | | | | | | Weighted Average Grant Date Fair Value | | | | Weighted Average Grant Date Fair Value | | Unvested at beginning of period | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unvested at end of period | | | | | | | | | |
| | | | | | | | | | | | Six Months Ended June 30, 2025 | | | | | | | | | | | | Weighted Average Grant Date Fair Value | | | | Weighted Average Grant Date Fair Value | | Unvested at beginning of period | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unvested at end of period | | | | | | | | | |
|
Stock Options Outstanding |
| | | | | | | | | | | | Six Months Ended June 30, 2025 | | | | | | | | | | Incentive Options Weighted Average Exercise Price | | Outstanding at beginning of period | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Outstanding at end of period | | | | | | | | | |
1As the Reload and Staking Options were one-time grants at the IPO, the weighted average exercise price for any movements in these awards will perpetually be $23.50. As such, the values are not presented in the table above. | | | | | | | | | | | | Six Months Ended June 30, 2025 | | | | Reload Class C Incentive Units | | Staking Class C Incentive Units | | | | Class C Incentive Units Weighted Average Participation Threshold | | Unvested at beginning of period | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unvested at end of period | | | | | | | | | |
|
Performance-Based Awards, Valuation Assumptions |
The fair values of the performance-based awards granted during the six months ended June 30, 2025, were determined using the Monte Carlo simulation valuation model with the following assumptions: | | | | | | | | | | | | RYAN stock price at valuation date | | |
|
Recognized and Unrecognized Equity-Based Compensation Costs |
As of June 30, 2025, the unrecognized equity-based compensation expense related to each type of equity-based compensation award described above and the related weighted-average remaining expense period were as follows: | | | | | | | | Weighted Average Remaining Expense Period (Years) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Reload Class C Incentive Units | | | | | Staking Class C Incentive Units | | | | | | | | | | | | | | | Total unrecognized equity-based compensation expense | | | | |
The following table includes the equity-based compensation the Company recognized by award type from the view of expense related to pre-IPO and post-IPO awards. The table also presents the unrecognized equity-based compensation expense as of June 30, 2025, in the same view. | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | | | | | | | | | | | | | | | | | | | | | | | IPO RSUs and Staking Options | | | | | | | | | | | IPO RLUs and Staking Class C Incentive Units | | | | | | | | | | | Incremental Restricted Stock and Reload Options | | | | | | | | | | | Incremental Restricted Common Units and Reload Class C Incentive Units | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Post-IPO incentive awards | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total equity-based compensation expense | | | | | | | | | | |
|
Aggregate Intrinsic Values and Weighted Average Remaining Contractual Terms of Stock Options Outstanding and Exercisable |
The aggregate intrinsic values and weighted average remaining contractual terms of Stock Options outstanding and exercisable as of June 30, 2025, were as follows: | | | Aggregate intrinsic value ($ in thousands): | | | Reload Options outstanding | | | Reload Options exercisable | | | Staking Options outstanding | | | Staking Options exercisable | | | Incentive Options outstanding | | | Incentive Options exercisable | | | Weighted-average remaining contractual term (in years): | | | Reload Options outstanding | | | Reload Options exercisable | | | Staking Options outstanding | | | Staking Options exercisable | | | Incentive Options outstanding | | | Incentive Options exercisable | | |
|